BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BID |
BID: BH3-interacting domain death agonist |
119.000 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
119.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
O
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
119.000 |
Evidence |
|
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
STAT3 |
|
119.000 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
119.000 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
119.000 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
119.000 |
Evidence |
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
119.000 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
119.000 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
119.000 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
119.000 |
Evidence |
|